{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05122234",
      "OrgStudyIdInfo": {
        "OrgStudyId": "54/FI/P-KCOVID-19.2B3/IX/2020"
      },
      "Organization": {
        "OrgFullName": "Indonesia University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19",
      "OfficialTitle": "Effectiveness and Safety Profile of Mesenchymal Stem Cell Secretomes as a Treatment for Severe Cases of COVID-19"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2021",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "August 10, 2020",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 30, 2021",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 14, 2021",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "November 13, 2021",
      "StudyFirstSubmitQCDate": "November 13, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 16, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "November 13, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "November 16, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Murdani abdullah",
        "ResponsiblePartyInvestigatorTitle": "Prof. M.D., PhD, FACG, FASGE",
        "ResponsiblePartyInvestigatorAffiliation": "Indonesia University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Indonesia University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This study is a multi-centre randomized controlled trial involving severe covid-19 patients. The intervention group will receive mesenchymal stem cell secretomes and standard covid-19 therapy, while the control group receive placebo and standard covid-19 therapy. Clinical presentation, inflamatory marker, laboratory and radiological parameters, RT-PCR conversion, safety profile, and mortality rate will be monitored for a maximum of 14 days after intervention."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "COVID-19"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Severe Covid-19",
          "secretome",
          "mesenchymal stem cell",
          "cytokine"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "40",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Secretome - mesenchymal stem cell group (n = 20)",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "This group will be given secretome - mesenchymal stem cell and COVID-19 standard therapy",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Injection of secretome - mesenchymal stem cell",
                "Drug: Standard treatment of Covid-19"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control ( n= 20)",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "This group will be given placebo and COVID-19 standard therapy",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Placebo",
                "Drug: Standard treatment of Covid-19"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Injection of secretome - mesenchymal stem cell",
            "InterventionDescription": "Secretome will be given once at a dose of 15 ml per administration dissolved in 100 ml of normal saline. The administration is done intravenously for 60 minutes.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Secretome - mesenchymal stem cell group (n = 20)"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Placebo",
            "InterventionDescription": "Normal saline",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control ( n= 20)"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Standard treatment of Covid-19",
            "InterventionDescription": "Standard treatment of Covid-19 based on national protocol.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control ( n= 20)",
                "Secretome - mesenchymal stem cell group (n = 20)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Assessment of inflamation marker levels",
            "PrimaryOutcomeDescription": "The inflamatory marker assessed in this study is IL-6, IL-10, LIF, VEGF, and Ferritin. The inflamatory marker level will assess on day 0 (before intervention), day 7 after intervention, and day 14 after intervention.",
            "PrimaryOutcomeTimeFrame": "Day 0 (before intervention), day 7, day 14"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Assessment of clinical outcome",
            "SecondaryOutcomeDescription": "Clinical outcome assessed in this study were body temperature, oxygen saturation, respiratory rate, shortness of breath, cough, and phlegm on cough.",
            "SecondaryOutcomeTimeFrame": "before and after intervention (maximum 14 days after intervention)"
          },
          {
            "SecondaryOutcomeMeasure": "Assessment of laboratory routine",
            "SecondaryOutcomeDescription": "Laboratory routine assessed in this study is NLR, lymphocyte count, thrombocytes count, CRP, blood gas analysis, bilirubin, albumin, SGOT, SGPT, ureum/creatinin, glomerular filtration rate (GFR), electrolyte, myoglobin, troponin, D-dimer.",
            "SecondaryOutcomeTimeFrame": "before and after intervention (maximum 14 days after intervention)"
          },
          {
            "SecondaryOutcomeMeasure": "Assessment of photo thorax",
            "SecondaryOutcomeDescription": "Photo thorax will assess before and after intervention",
            "SecondaryOutcomeTimeFrame": "before and after intervention (maximum 14 days after intervention)"
          },
          {
            "SecondaryOutcomeMeasure": "Assessment of RT-PCR conversion",
            "SecondaryOutcomeDescription": "RT-PCR conversion will assess before and after intervention",
            "SecondaryOutcomeTimeFrame": "before and after intervention (maximum 14 days after intervention)"
          },
          {
            "SecondaryOutcomeMeasure": "Mortality rate",
            "SecondaryOutcomeTimeFrame": "maximum 14 days after intervention"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAll individuals aged 18 to 65 years\nIt has been confirmed positive for COVID-19 by throat swab / sputum / brochoalveolar lavage (BAL) with real-time reverse transcription polymerase chain reaction (RT-PCR)\nCategorized as a severe case of COVID-19 patient\nAgree to participate and sign the informed consent\n\nExclusion Criteria:\n\nHistory of allergy to penicillin, streptomycin, and amphotericin-B\nHave any cancer conditions\nActive in other intervention studies\nHave had other intervention studies in the last 3 months",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Murdani Abdullah, Prof. M.D., PhD, FACG, FASGE",
            "OverallOfficialAffiliation": "Departemen of Internal Medicine, Faculty of Medicine, University of Indonesia",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "RSUPN Dr. Cipto Mangunkusumo",
            "LocationCity": "Jakarta Pusat",
            "LocationState": "DKI Jakarta",
            "LocationCountry": "Indonesia"
          },
          {
            "LocationFacility": "RSUP Fatmawati",
            "LocationCity": "Jakarta",
            "LocationState": "DKI Jakarta",
            "LocationCountry": "Indonesia"
          },
          {
            "LocationFacility": "RSUP Persahabatan",
            "LocationCity": "Jakarta",
            "LocationState": "DKI Jakarta",
            "LocationCountry": "Indonesia"
          },
          {
            "LocationFacility": "Rumah Sakit Universitas Indonesia",
            "LocationCity": "Depok",
            "LocationState": "Jawa Barat",
            "LocationCountry": "Indonesia"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000086382",
            "ConditionMeshTerm": "COVID-19"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012141",
            "ConditionAncestorTerm": "Respiratory Tract Infections"
          },
          {
            "ConditionAncestorId": "D000007239",
            "ConditionAncestorTerm": "Infections"
          },
          {
            "ConditionAncestorId": "D000011024",
            "ConditionAncestorTerm": "Pneumonia, Viral"
          },
          {
            "ConditionAncestorId": "D000011014",
            "ConditionAncestorTerm": "Pneumonia"
          },
          {
            "ConditionAncestorId": "D000014777",
            "ConditionAncestorTerm": "Virus Diseases"
          },
          {
            "ConditionAncestorId": "D000018352",
            "ConditionAncestorTerm": "Coronavirus Infections"
          },
          {
            "ConditionAncestorId": "D000003333",
            "ConditionAncestorTerm": "Coronaviridae Infections"
          },
          {
            "ConditionAncestorId": "D000030341",
            "ConditionAncestorTerm": "Nidovirales Infections"
          },
          {
            "ConditionAncestorId": "D000012327",
            "ConditionAncestorTerm": "RNA Virus Infections"
          },
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M2562",
            "ConditionBrowseLeafName": "COVID-19",
            "ConditionBrowseLeafAsFound": "COVID-19",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9435",
            "ConditionBrowseLeafName": "Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5520",
            "ConditionBrowseLeafName": "Communicable Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14130",
            "ConditionBrowseLeafName": "Respiratory Tract Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13056",
            "ConditionBrowseLeafName": "Pneumonia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13066",
            "ConditionBrowseLeafName": "Pneumonia, Viral",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16674",
            "ConditionBrowseLeafName": "Virus Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19643",
            "ConditionBrowseLeafName": "Coronavirus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5707",
            "ConditionBrowseLeafName": "Coronaviridae Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22838",
            "ConditionBrowseLeafName": "Nidovirales Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14301",
            "ConditionBrowseLeafName": "RNA Virus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}